← Research library

C-terminal GHK-D-Ala for experimental infected wounds — RU2681216C1

Patent disclosure · 2019

What the patent describes
Three comparison groups of male Wistar rats weighing 180–220 g. Standardized 1.5 × 1.5 cm wounds were cleaned and debrided. GHK-D-Ala or unbound GHK at 0.5 µg/kg was injected intradermally at the wound edges once daily for 10 days. Saline controls received the same 0.1 mL volume. The accessible text does not state the number of rats in each group.
Reported evidence
The inventors report faster reduction of wound area with GHK-D-Ala and unbound GHK than with saline from day 3 in male Wistar rats.

Reported patent results

Findings described in words

The inventors report faster reduction of wound area with GHK-D-Ala and unbound GHK than with saline from day 3 in male Wistar rats.

Three comparison groups of male Wistar rats weighing 180–220 g. Standardized 1.5 × 1.5 cm wounds were cleaned and debrided. GHK-D-Ala or unbound GHK at 0.5 µg/kg was injected intradermally at the wound edges once daily for 10 days. Saline controls received the same 0.1 mL volume. The accessible text does not state the number of rats in each group.

Population or model Three comparison groups of male Wistar rats weighing 180–220 g. Standardized 1.5 × 1.5 cm wounds were cleaned and debrided. GHK-D-Ala or unbound GHK at 0.5 µg/kg was injected intradermally at the wound edges once daily for 10 days. Saline controls received the same 0.1 mL volume. The accessible text does not state the number of rats in each group.

Results · Original grant, wound experiment, figures and claim.
MeasureResultComparison, timing and statistics
Wound area and healing rateThe patent reports smaller wounds and faster healing with both peptide arms compared with saline from day 3.Reported p<0.05 versus saline
Comparison with unbound GHKThe inventors describe more pronounced healing with GHK-D-Ala. A pairwise p value is not supplied in the text.

The dose and results concern an intradermal animal experiment. The patent uses a C-terminal D-alanine analogue.

Source for these results ↗ · Reviewed 2026-11-15

Patent claims and provenance

Modified analogue. Claims intradermal delivery of Gly–His–Lys–D-Ala at the edges of experimentally infected wounds after wound preparation.

The applicant’s Wistar-rat example compares the C-terminal analogue with unbound GHK and saline. It shares inventors and a wound model with RU2681310C1, so independence of the experiments remains unverified.

Publication
RU2681216C1 ↗ · 2019-03-05
Earliest priority / filing
2018-09-05 / 2018-09-05
Original applicant / assignee
Kursk State Medical University
Indexed status
Not shown; official status unverified · checked 2026-11-15
Patent family
65632761 · family publications are related filings, not independent studies.
Original title, inventors and related publications

Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala

Inventors: K. K. Rakhmetova; I. I. Bobyntsev; A. I. Bezhin; M. Yu. Smakhtin; E. A. Gribanova.

RU2681216C1

Original patent PDF ↗

Patent collection and status interpretation →

Study limitations and source details

Study limitations

  • The applicant’s Wistar-rat example compares the C-terminal analogue with unbound GHK and saline. It shares inventors and a wound model with RU2681310C1, so independence of the experiments remains unverified.
  • The dose and results concern an intradermal animal experiment. The patent uses a C-terminal D-alanine analogue.
  • Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
  • Status labels are Google Patents index snapshots for the displayed publication or application; each record lists the review date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.

Related publications may describe some of the same participants or experiments.

Source details

Patent publication · Original patent text and indexed metadata

Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.

Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.

Sources checked

Citation

Published

Patent / reported experimentsFull text available

K. K. Rakhmetova, I. I. Bobyntsev, A. I. Bezhin, M. Yu. Smakhtin, E. A. Gribanova. C-terminal GHK-D-Ala for experimental infected wounds — RU2681216C1 RU2681216C1 · patent family 65632761

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards